Apixaban and risk of myocardial infarction: meta-analysis of randomized controlled trials [PDF]
, 2015 The coagulation system contributes greatly to the evolution of myocardial infarction (MI). Anticoagulation may reduce the occurrence of MI as monotherapy or with con- comitant use of aspirin.
Aradi, Dániel +3 more
core
GRADE Evidence to Decision (EtD) frameworks : a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines [PDF]
, 2016 Funding: Work on this article has been partially funded by the European Commission FP7 Program (grant agreement 258583) as part of the DECIDE project. Sole responsibility lies with the authors; the European Commission is not responsible for any use that ...
the GRADE Working Group
core +1 more source
Traumatic or Nontraumatic: A Case of Spinal Subdural Hematoma Caused by Multiple Factors
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT Spinal subdural hematoma (SSDH) is a rare but potentially life‐threatening complication following spinal decompression surgery. Vertebral compression fractures in elderly patients are commonly associated with osteoporosis. This case illustrates how the interplay of bleeding diatheses, coagulopathy, and medication interactions may collectively ...
Cheng Wang, Bingjun Lei, Yujie Zhang
wiley +1 more source
The effect of apixaban on the pharmacokinetics of digoxin and atenolol in healthy subjects
Clinical Pharmacology: Advances and Applications, 2017 Charles Frost,1 Yan Song,1 Zhigang Yu,2 Jessie Wang,3 Lois S Lee,4 Alan Schuster,5 Allyson Pollack,1 Frank LaCreta1 1Exploratory Clinical and Translational Research, Bristol-Myers Squibb, Princeton, NJ, USA; 2Medical Sciences, Amgen Asia R&D Center ...
Frost C +7 more
doaj
Managing patients taking novel oral anticoagulants (NOAs) in dentistry: A discussion paper on clinical implications [PDF]
, 2016 Background The aim of this paper is to contribute to the discussion on how to approach patients taking new orally administered anticoagulants (NOAs) dabigatran etexilate (a direct thrombin inhibitor), rivaroxaban and apixaban (factor Xa inhibitors ...
Costantinides, Fulvia +3 more
core +1 more source
Euglycemic Ketoacidosis Induced by Dapagliflozin in a Non‐Diabetic Patient With Cardiac Amyloidosis
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT Dapagliflozin, though beneficial in heart failure, can rarely cause euglycemic ketoacidosis even in non‐diabetic patients. Clinicians should maintain a high index of suspicion for metabolic acidosis in patients on SGLT2 inhibitors presenting with unexplained illness, regardless of blood glucose level.
Salhamoud Abdelfatah Saleh Hamoud +1 more
wiley +1 more source
Self‐poisoning with 60 tablets of Apixaban, a pharmacokinetics case report [PDF]
, 2018 Bénédicte Franck +8 more
openalex +1 more source
Clinical Case Reports, Volume 14, Issue 1, January 2026.ABSTRACT Multi‐chamber intracardiac thrombi are a rare and high‐risk complication in dilated cardiomyopathy, even during sinus rhythm. This case highlights the associated dangers of hemodynamic compromise and systemic embolization. Management requires vigilant anticoagulation and close monitoring to balance thromboembolic and bleeding risks.
Eba Fufa +10 more
wiley +1 more source
A Probable Life-Saving Switch from Apixaban to Phenprocoumon [PDF]
, 2015 Claudia Stöllberger, Josef Finsterer
openalex +1 more source
Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation
, 2013 The most significant complication of atrial fibrillation (AF) is thromboembolic stroke. Furthermore, the consequences of AF-related stroke tend to be more severe than those of other aetiologies.
Connelly, D.T., Lang, N.N.
core +1 more source